Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson K Mukonzo

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Multidisciplinary Healthcare|August 31, 2013
Over-the-counter suboptimal dispensing of antibiotics in UgandaJackson K Mukonzo, Proscovia M Namuwenge, Gildo Okure, et al.
HIV/AIDS (Auckland, N.Z.)|December 19, 2013
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve UgandansSarah Nanzigu, Ronald Kiguba, Joseph Kabanda, et al.
AIDS Research and Therapy|April 16, 2024
Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trialSilvano S Twinomujuni, Esther C Atukunda, Jackson K Mukonzo, et al.
Pharmacogenomics|April 6, 2016
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa populationJackson K Mukonzo, Ronald K Bisaso, Jasper Ogwal-Okeng, et al.
Clinical and Translational Science|November 14, 2023
Expanding regulatory science: Regulatory complementarity and relianceJackson K Mukonzo, Helen Byomire Ndagije, George Tsey Sabblah, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 3, 2019
Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patientsJackson K Mukonzo, Allan Kengo, Bisaso Kutesa, et al.
Journal of Multidisciplinary Healthcare|May 8, 2013
Tips for charting the course of a successful health research careerLawrence Mbuagbaw, Frederick Morfaw, John-Eudes L Kunda, et al.
Drugs in R&D|November 21, 2015
Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant WomenCharles O Odongo, Kuteesa R Bisaso, Muhammad Ntale, et al.
BMC Infectious Diseases|June 6, 2013
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort studyJackson K Mukonzo, Alphonse Okwera, Neoline Nakasujja, et al.
Clinical Pharmacokinetics|July 12, 2011
HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjectsJackson K Mukonzo, Sarah Nanzigu, Dinko Rekić, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Multidisciplinary Healthcare|August 31, 2013
Over-the-counter suboptimal dispensing of antibiotics in UgandaJackson K Mukonzo, Proscovia M Namuwenge, Gildo Okure, et al.
HIV/AIDS (Auckland, N.Z.)|December 19, 2013
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve UgandansSarah Nanzigu, Ronald Kiguba, Joseph Kabanda, et al.
AIDS Research and Therapy|April 16, 2024
Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trialSilvano S Twinomujuni, Esther C Atukunda, Jackson K Mukonzo, et al.
Pharmacogenomics|April 6, 2016
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa populationJackson K Mukonzo, Ronald K Bisaso, Jasper Ogwal-Okeng, et al.
Clinical and Translational Science|November 14, 2023
Expanding regulatory science: Regulatory complementarity and relianceJackson K Mukonzo, Helen Byomire Ndagije, George Tsey Sabblah, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 3, 2019
Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patientsJackson K Mukonzo, Allan Kengo, Bisaso Kutesa, et al.
Journal of Multidisciplinary Healthcare|May 8, 2013
Tips for charting the course of a successful health research careerLawrence Mbuagbaw, Frederick Morfaw, John-Eudes L Kunda, et al.
Drugs in R&D|November 21, 2015
Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant WomenCharles O Odongo, Kuteesa R Bisaso, Muhammad Ntale, et al.
BMC Infectious Diseases|June 6, 2013
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort studyJackson K Mukonzo, Alphonse Okwera, Neoline Nakasujja, et al.
Clinical Pharmacokinetics|July 12, 2011
HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjectsJackson K Mukonzo, Sarah Nanzigu, Dinko Rekić, et al.
Pageof 3